Published in J Neurol Sci on November 20, 2010
Opinions about the use of brain natriuretic peptide among acute ischemic stroke patients. Ann Indian Acad Neurol (2013) 0.90
Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol (2012) 0.84
Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume. Int J Med Sci (2012) 0.84
Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease. Aging (Albany NY) (2014) 0.78
Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes. Dis Markers (2015) 0.76
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron (2009) 3.11
B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology (2013) 2.98
Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol (2005) 2.33
Genetic dissection of the circuit for hand dexterity in primates. Nature (2012) 2.01
Brain natriuretic peptide on admission as a biological marker of long-term mortality in ischemic stroke survivors. Eur Neurol (2013) 2.00
Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study. J Neurol Sci (2011) 1.73
Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci (2007) 1.67
Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A (2009) 1.64
The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke. Stroke (2008) 1.64
Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register. Stroke (2009) 1.63
Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol (2004) 1.61
Non-cell-autonomous roles for the planar cell polarity gene Vangl2 in development of the coronary circulation. Circ Res (2008) 1.60
Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. Cell (2002) 1.59
Molecular identity of periglomerular and short axon cells. J Neurosci (2010) 1.55
Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke (2004) 1.50
IV t-PA therapy in acute stroke patients with atrial fibrillation. J Neurol Sci (2008) 1.50
The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun (2009) 1.49
Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization. Int J Stroke (2012) 1.49
Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development. J Neurochem (2002) 1.48
Source of microembolic signals in patients with high-grade carotid stenosis. Stroke (2002) 1.48
Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- Multicenter Retrospective Cohort Study in Japan. Circ J (2015) 1.47
Contrast transcranial Doppler can diagnose large patent foramen ovale. Cerebrovasc Dis (2009) 1.42
Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis (2013) 1.40
Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study. J Hypertens (2015) 1.40
A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein. Hum Gene Ther (2011) 1.34
Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus. J Neurosci (2007) 1.32
Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci (2006) 1.30
Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. J Neurosci (2011) 1.28
FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci (2010) 1.27
Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci (2003) 1.27
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. Biochem Biophys Res Commun (2009) 1.21
Survival of developing motor neurons mediated by Rho GTPase signaling pathway through Rho-kinase. J Neurosci (2004) 1.21
Intravenous TPA for very old stroke patients. Eur Neurol (2005) 1.21
Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Neurobiol Aging (2006) 1.18
Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons. J Neurochem (2004) 1.18
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem (2006) 1.16
Enhanced carotid plaque on contrast-enhanced ultrasound is associated with plaque instability and rupture. Int J Stroke (2012) 1.15
Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol (2008) 1.15
Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein. J Neurosci Res (2007) 1.14
Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J Neurosci (2007) 1.14
Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J (2008) 1.13
Elovl6 promotes nonalcoholic steatohepatitis. Hepatology (2012) 1.13
Mouse Elovl-6 promoter is an SREBP target. Biochem Biophys Res Commun (2008) 1.12
Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis (2011) 1.12
Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum Gene Ther (2007) 1.12
Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med (2009) 1.11
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis (2010) 1.11
Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med (2009) 1.09
A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome. J Neurol Sci (2008) 1.08
Differentiation of the dopaminergic phenotype in the olfactory system of neonatal and adult mice. J Comp Neurol (2004) 1.08
Selective neural pathway targeting reveals key roles of thalamostriatal projection in the control of visual discrimination. J Neurosci (2011) 1.07
Reduced retinal ganglion cell complex thickness in patients with posterior cerebral artery infarction detected using spectral-domain optical coherence tomography. Jpn J Ophthalmol (2012) 1.07
Large numbers of stroke physicians should be used to treat large numbers of stroke patients with IV rt-PA. J Neurol Sci (2010) 1.07
Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes (2008) 1.05
Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res (2008) 1.05
Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein. Hum Gene Ther (2011) 1.05
Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem (2008) 1.05
Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett (2004) 1.04
A case of stroke due to tumor emboli associated with metastatic cardiac liposarcoma. Intern Med (2011) 1.04